索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]贾,赫,李碧澄,等.Toll样受体4在心血管疾病中的作用[J].国际心血管病杂志,2017,03:143-145.
点击复制

Toll样受体4在心血管疾病中的作用(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2017年03期
页码:
143-145
栏目:
综述
出版日期:
2017-05-30

文章信息/Info

Title:
-
作者:
贾; 赫; 李碧澄; 田; 野
150001 哈尔滨医科大学附属第一医院心血管内科
Author(s):
-
关键词:
心肌组织;  炎症反应;  Toll样受体4;  心血管疾病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2017.03.005
文献标识码:
-
摘要:
Toll样受体4(TLR4)是最早发现的TLRs家族成员,可介导心肌组织炎症反应,参与心肌炎、心肌梗死、缺血再灌注损伤、心力衰竭等病理生理过程。该文介绍TLR4在心血管疾病中的作用。
Abstract:
-

参考文献/References

[1] Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity[J]. Nature, 1997, 388(6640):394-397.
[2] Jiang Z, Georgel P, Du X, et al. CD14 is required for MyD88-independent LPS signaling[J]. Nat Immunol, 2005, 6(6):565-570.
[3] Nagai Y, Akashi S, Nagafuku M, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution[J]. Nat Immunol, 2002, 3(7):667-672.
[4] Takeda K, Akira S. Toll-like receptors in innate immunity[J]. Int Immunol, 2005, 17(1):1-14.
[5] Liew FY, Xu D, Brint EK, et al. Negative regulation of toll-like receptor-mediated immune responses[J]. Nat Rev Immunol, 2005, 5(6):446-458.
[6] Seimon TA, Obstfeld A, Moore KJ, et al. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages[J]. Proc Natl Acad Sci U S A, 2006, 103(52):19794-19799.
[7] Fairweather D, Yusung S, Frisancho S, et al. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication[J]. J Immunol, 2003, 170(9):4731-4737.
[8] Riad A, Westermann D, Zietsch C, et al. TRIF is a critical survival factor in viral cardiomyopathy[J]. J Immunol, 2011, 186(4):2561-2570.
[9] Fuse K, Chan G, Liu Y, et al. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type Ⅰ interferon production[J]. Circulation, 2005, 112(15):2276-2285.
[10] Bachmaier K, Toya S, Malik AB. Therapeutic administration of the chemokine CXCL1/KC abrogates autoimmune inflammatory heart disease[J]. PLoS One, 2014, 9(2):e89647.
[11] Machino-Ohtsuka T, Tajiri K, Kimura T, et al. Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiation[J].J Am Heart Assoc, 2014, 3(6):e001052.
[12] Jenke A, Wilk S, Poller W, et al. Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury[J]. Cardiovasc Res, 2013, 99(3):422-431.
[13] Frangogiannis NG. Inflammation in cardiac injury, repair and regeneration[J]. Curr Opin Cardiol, 2015, 30(3):240-245.
[14] Rohde D, Sch?n C, Boerries M, et al. S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4[J]. EMBO Mol Med, 2014, 6(6):778-794.
[15] Schiopu A, Cotoi OS. S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease[J]. Mediators Inflamm, 2013, 2013:828354.
[16] Zhang W, Lavine KJ, Epelman S,et al. Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo[J]. J Am Heart Assoc, 2015, 4(6):e001993.
[17] Haas B, Leonard F, Ernens I, et al. Adenosine reduces cell surface expression of toll-like receptor 4 and inflammation in response to lipopolysaccharide and matrix products[J]. J CardiovascTranslRes, 2011, 4(6):790-800.
[18] Liu L, Wang Y, Cao ZY, et al. Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction[J]. J Cell Mol Med, 2015, 19(12):2728-2740.
[19] Soraya H, Clanachan AS, Rameshrad M, et al. Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction[J]. Eur J Pharmacol, 2014, 737:77-84.
[20] Lu M, Tang F, Zhang J, et al. Astragaloside Ⅳ attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway[J]. Phytother Res, 2015, 29(4):599-606.
[21] 蔡文科, 张 燕, 李吉国, 等.κ阿片受体激动剂通过调控Toll样受体4/核因子-κB信号通路保护大鼠缺血再灌注心肌[J]. 中华心血管病杂志, 2014, 42(10):866-872.
[22] 刘千萍, 潘坤颖, 周 欣, 等.Toll样受体2和4在大鼠心肌缺血/再灌注损伤模型中的动态表达[J]. 中国应用生理学杂志, 2013, 29(4):326-330.
[23] Wang C, Sun H, Song Y, et al. Pterostilbene attenuates inflammation in rat heart subjected to ischemia-reperfusion: role of TLR4/NF-κB signaling pathway[J]. Int J Clin Exp Med, 2015, 8(2):1737-1746.
[24] Shimamoto A, Chong AJ, Yada M, et al. Inhibition of Toll like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury[J]. Circulation, 2006, 114(1 Suppl):I270-I274.
[25] Chen Y, Rothnie C, Spring D, et al. Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury[J]. Cytokine, 2014, 69(2):255-262.
[26] Frantz S, Kobzik L, Kim YD, et al. Toll4(TLR4)expression in cardiac myocytes in normal and failing myocardium[J]. J Clin Invest, 1999, 104(3):271-280.
[27] Boyd JH, Mathur S, Wang Y, et al. Toll-like receptor stimulation in cardiomyocytes decreases contractility and initiates an NF-kappaB dependent inflammatory response[J]. Cardiovasc Res, 2006, 72(3):384-393.
[28] Timmers L, Sluijter JP, van Keulen JK, et al. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction[J]. Circ Res, 2008, 102(2):257-264.
[29] Riad A, J?ger S, Sobirey M, et al. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice[J]. J Immunol, 2008, 180(10):6954-6961.
[30] Satoh M, Shimoda Y, Maesawa C, et al. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction[J]. Int J Cardiol, 2006, 109(2):226-234.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81371709)
通信作者:田 野,Email:yetian@ems.hrbmu.edu.cn
更新日期/Last Update: 2017-05-30